Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

This study is ongoing, but not recruiting participants.

Study NCT00607451 Information provided by Neurim Pharmaceuticals Ltd.

First Received: January 22, 2008 Last Updated: June 9, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2012
Estimated Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)